The role of Technology Translation at Sanger: Our Case Studies

Driving innovation in Genomics through technology translation, our case studies show the journeys of very different technologies. All stemming from Sanger research, they have turned into products and services creating a real impact on society. From our very first spin-out (Kymab) through to the stories of three scientific teams working on Malaria. 

For Industry

We create technologies and therapies of tomorrow through open dialogue with our commercial partners. Get in touch with any member of our business development team today to discuss partnering

Find out more

For Researchers

We use our expertise in all aspects of technology identification, assessment, IP protection, development and commercialisation, to help you develop your research into a product or service that creates healthcare benefit

Find out more

Spin-Outs

Spin-outs

We’ve supported the creation of four spin-out companies to date; to learn more about Congenica, Kymab, Microbiotica and VHSquared

Find out more

Licenses

Licences

Licensing is one way we disseminate knowledge and resources to benefit the scientific community and improve healthcare

Find out more

Collaborations

Collaborations

Strategic partnerships marry the formidable science base of the Institute with the capabilities of commercial partners to add value to our technologies

Find out more

Sanger Technologies

We create technologies and therapies of tomorrow through open dialogue with our many partners. For a list of all current partnership opportunities that fall into either one or more than one of these types-software, data, biological tools or kits; browse the Sanger Technologies page and get in touch today.

Wellcome Sanger Institute